Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 May;21(5):604-605.
doi: 10.1016/S1473-3099(21)00058-X. Epub 2021 Feb 15.

Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran - Authors' reply

Maryam Darvishian  1 , Maryam Sharafkhah  2 , Hossein Poustchi  2 , Reza Malekzadeh  3
Affiliations
Comment

Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran - Authors' reply

Maryam Darvishian et al. Lancet Infect Dis. 2021 May.
No abstract available

PubMed Disclaimer

Comment on

  • SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study.
    Poustchi H, Darvishian M, Mohammadi Z, Shayanrad A, Delavari A, Bahadorimonfared A, Eslami S, Javanmard SH, Shakiba E, Somi MH, Emami A, Saki N, Hormati A, Ansari-Moghaddam A, Saeedi M, Ghasemi-Kebria F, Mohebbi I, Mansour-Ghanaei F, Karami M, Sharifi H, Pourfarzi F, Veisi N, Ghadimi R, Eghtesad S, Niavarani A, Ali Asgari A, Sadeghi A, Sorouri M, Anushiravani A, Amani M, Kaveh S, Feizesani A, Tabarsi P, Keyvani H, Markarian M, Shafighian F, Sima A, Sadjadi A, Radmard AR, Mokdad AH, Sharafkhah M, Malekzadeh R. Poustchi H, et al. Lancet Infect Dis. 2021 Apr;21(4):473-481. doi: 10.1016/S1473-3099(20)30858-6. Epub 2020 Dec 15. Lancet Infect Dis. 2021. PMID: 33338441 Free PMC article.
  • Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran.
    Ghafari M, Kadivar A, Katzourakis A. Ghafari M, et al. Lancet Infect Dis. 2021 May;21(5):602-603. doi: 10.1016/S1473-3099(21)00053-0. Epub 2021 Feb 15. Lancet Infect Dis. 2021. PMID: 33600759 Free PMC article. No abstract available.

References

    1. Poustchi H, Darvishian M, Mohammadi Z, et al. SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study. Lancet Infect Dis. 2020 doi: 10.1016/S1473-3099(20)30858-6. published online Dec 15. - DOI - PMC - PubMed
    1. Ghafari M, Kadivar A, Katzourakis A. Excess deaths associated with the Iranian COVID-19 epidemic: a province-level analysis. medRxiv. 2020 doi: 10.1101/2020.12.07.20245621. published online Dec 8. (preprint). - DOI - PMC - PubMed
    1. Ministry of Health and Medical Education . MoHME; Tehran: 2020. Analysis of the latest seroepidemiological findings. Summary of the results of scattered seroepidemiological studies conducted in the country, 7th report by COVID-19 Epidemiological Analysis Committee.
    1. Shakiba M, Nazemipour M, Salari A, et al. Seroprevalence of SARS-CoV-2 in Guilan province, Iran, April 2020. Emerg Infect Dis. 2020 doi: 10.3201/eid2702.201960. published online Dec 21. - DOI - PMC - PubMed
    1. Lumley SF, O'Donnell D, Stoesser NE, et al. Antibody status and incidence of SARS-CoV-2 infection in health care workers. N Engl J Med. 2020 doi: 10.1056/nejmoa2034545. published online Dec 23. - DOI - PMC - PubMed

Substances